Prescriptions made by Jinesh Mehta

Data for 2018

2,141

Medicare Part D Prescriptions Filled, Including Refills

Rank: 165 out of 616 providers in this state and specialty

$3.85M

Total Retail Price of All Prescriptions

Rank: 15 out of 616 providers in this state and specialty

357

Patients Receiving at Least One Drug in Part D

Rank: 147 out of 616 providers in this state and specialty

92%

Patients 65 Years and Older

74

Average Age of Patients

Average age of patients for providers in this state and specialty is 72

Drug Categories

O

Opioid

An opioid drug. Prescription opioids (painkillers) can help alleviate certain kinds of pain in the short term but carry serious health risks.
A

Antibiotic

Used to treat bacterial infections but are often prescribed incorrectly to treat viral infections, such as chest colds or the flu.
P

Antipsychotic

Used to manage psychosis, principally in schizophrenia but also in a range of other psychotic disorders.

Prescription Data

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume. Rank in State ranks all providers that have the self-identified specialty of Pulmonary Disease in Florida and ranks the number of prescriptions that have been made for the specific drug.

Drug Name Rank in State Total Prescriptions Filled with Refills Prescript. to 65+ Patients Receiving this Drug Patients 65+ OAP
1 ANORO ELLIPTA
(UMECLIDINIUM BRM/VILANTEROL TR)
330
of 4430
2020 prescriptions
Less than 1% of all prescriptions
1860470 patients
13% of all patients
< 11
2 SPIRIVA
(TIOTROPIUM BROMIDE)
510
of 4520
1060 prescriptions
Less than 1% of all prescriptions
270 patients
8% of all patients
< 11
3 PREDNISONE1290
of 5140
1400 prescriptions
Less than 1% of all prescriptions
1190550 patients
15% of all patients
< 11
4 SILDENAFIL
(SILDENAFIL CITRATE)
20
of 740
1080 prescriptions
Less than 1% of all prescriptions
960230 patients
6% of all patients
< 11
5 SYMBICORT
(BUDESONIDE/FORMOTEROL FUMARATE)
1470
of 5100
960 prescriptions
Less than 1% of all prescriptions
780340 patients
10% of all patients
< 11
6 ADVAIR DISKUS
(FLUTICASONE PROPION/SALMETEROL)
900
of 4730
950 prescriptions
Less than 1% of all prescriptions
820240 patients
7% of all patients
< 11
7 MONTELUKAST SODIUM1860
of 4890
670 prescriptions
Less than 1% of all prescriptions
240 patients
7% of all patients
< 11
8 ADCIRCA
(TADALAFIL)
30
of 500
1030 prescriptions
Less than 1% of all prescriptions
760140 patients
4% of all patients
< 11
9 PROAIR HFA
(ALBUTEROL SULFATE)
910
of 4810
790 prescriptions
Less than 1% of all prescriptions
430 patients
12% of all patients
< 11
10 VENTOLIN HFA
(ALBUTEROL SULFATE)
1600
of 5130
790 prescriptions
Less than 1% of all prescriptions
350 patients
10% of all patients
< 11
11 BREO ELLIPTA
(FLUTICASONE/VILANTEROL)
1850
of 4910
670 prescriptions
Less than 1% of all prescriptions
170 patients
5% of all patients
< 11
12 LETAIRIS
(AMBRISENTAN)
100
of 700
690 prescriptions
Less than 1% of all prescriptions
320< 11< 11
13 STIOLTO RESPIMAT
(TIOTROPIUM BR/OLODATEROL HCL)
490
of 2550
550 prescriptions
Less than 1% of all prescriptions
140 patients
4% of all patients
< 11
14 FUROSEMIDE550
of 2340
360 prescriptions
Less than 1% of all prescriptions
160 patients
4% of all patients
< 11
15 FLUTICASONE PROPIONATE1430
of 4250
360 prescriptions
Less than 1% of all prescriptions
360180 patients
5% of all patients
180 patients
5% of all patients
16 SPIRIVA RESPIMAT
(TIOTROPIUM BROMIDE)
1010
of 3860
370 prescriptions
Less than 1% of all prescriptions
370< 11< 11
17 ARNUITY ELLIPTA
(FLUTICASONE FUROATE)
270
of 1730
440 prescriptions
Less than 1% of all prescriptions
< 11< 11
18 UPTRAVI
(SELEXIPAG)
50
of 250
460 prescriptions
Less than 1% of all prescriptions
460< 11< 11
19 ORENITRAM ER
(TREPROSTINIL DIOLAMINE)
70
of 220
360 prescriptions
Less than 1% of all prescriptions
360< 11< 11
20 FLOVENT HFA
(FLUTICASONE PROPIONATE)
390
of 2010
310 prescriptions
Less than 1% of all prescriptions
310< 11< 11
21 OFEV
(NINTEDANIB ESYLATE)
270
of 1650
340 prescriptions
Less than 1% of all prescriptions
340< 11< 11
22 XARELTO
(RIVAROXABAN)
180
of 660
180 prescriptions
Less than 1% of all prescriptions
180< 11< 11
23 DALIRESP
(ROFLUMILAST)
400
of 1720
250 prescriptions
Less than 1% of all prescriptions
< 11< 11
24 ADEMPAS
(RIOCIGUAT)
120
of 450
300 prescriptions
Less than 1% of all prescriptions
300< 11< 11
25 TRELEGY ELLIPTA
(FLUTICASONE/UMECLIDIN/VILANTER)
710
of 2970
260 prescriptions
Less than 1% of all prescriptions
260< 11< 11
26 TADALAFIL40
of 120
200 prescriptions
Less than 1% of all prescriptions
< 11< 11
27 ZAFIRLUKAST90
of 190
120 prescriptions
Less than 1% of all prescriptions
120< 11< 11
28 POTASSIUM CHLORIDE410
of 1130
240 prescriptions
Less than 1% of all prescriptions
< 11< 11
29 INCRUSE ELLIPTA
(UMECLIDINIUM BROMIDE)
1190
of 4070
190 prescriptions
Less than 1% of all prescriptions
< 11< 11
30 AZITHROMYCIN1050
of 4360
580 prescriptions
Less than 1% of all prescriptions
480 patients
13% of all patients
< 11A
31 OPSUMIT
(MACITENTAN)
210
of 440
200 prescriptions
Less than 1% of all prescriptions
< 11< 11
32 MYCOPHENOLATE MOFETIL140
of 220
130 prescriptions
Less than 1% of all prescriptions
130< 11< 11
33 PANTOPRAZOLE SODIUM580
of 1590
180 prescriptions
Less than 1% of all prescriptions
180< 11< 11
34 SPIRONOLACTONE190
of 420
160 prescriptions
Less than 1% of all prescriptions
< 11< 11
35 TRACLEER
(BOSENTAN)
90
of 230
130 prescriptions
Less than 1% of all prescriptions
00< 1100 patients
Less than 1% of all patients
36 MIDODRINE HCL10
of 50
120 prescriptions
Less than 1% of all prescriptions
00< 1100 patients
Less than 1% of all patients
37 ESBRIET
(PIRFENIDONE)
400
of 1290
110 prescriptions
Less than 1% of all prescriptions
110< 11< 11
38 HYDROCODONE-ACETAMINOPHEN
(HYDROCODONE/ACETAMINOPHEN)
240
of 380
110 prescriptions
Less than 1% of all prescriptions
110< 11< 11O
39 METHYLPREDNISOLONE700
of 1910
270 prescriptions
Less than 1% of all prescriptions
220 patients
6% of all patients
< 11
40 CIPROFLOXACIN HCL410
of 1260
130 prescriptions
Less than 1% of all prescriptions
130 patients
4% of all patients
< 11A